Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00379041 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma

StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. 3 versions Re-verified since Feb 14, 2023, no change to tracked fieldsv20-v22
  2. Primary completion date: Oct 1998 to Oct 1, 1998
    • Start date: Sep 1993 to Sep 1, 1993
    v19
  3. 2 versions Re-verified since Oct 25, 2016, no change to tracked fieldsv17-v18
  4. Primary completion date: Oct 1998v16
  5. Interventions: bleomycin sulfate (Biological), doxorubicin hydrochloride (Drug), mechlorethamine hydrochloride (Drug), prednisone (Drug), procarbazine… to bleomycin sulfate (Biological), doxorubicin hydrochloride (Drug), mechlorethamine hydrochloride (Drug), prednisone (Drug), procarbazine…v15
Show 13 earlier versionsHide 13 earlier versions
  1. Publications: details revised at 1 of 3 entriesv14
  2. Interventions: bleomycin (Biological), doxorubicin hydrochloride (Drug), mechlorethamine hydrochloride (Drug), prednisone (Drug), procarbazine… to bleomycin sulfate (Biological), doxorubicin hydrochloride (Drug), mechlorethamine hydrochloride (Drug), prednisone (Drug), procarbazine…v13
  3. Interventions: bleomycin (Drug), doxorubicin hydrochloride (Drug), mechlorethamine hydrochloride (Drug), prednisone (Drug), procarbazine hydrochloride… to bleomycin (Biological), doxorubicin hydrochloride (Drug), mechlorethamine hydrochloride (Drug), prednisone (Drug), procarbazine…v12
  4. Interventions: bleomycin (Drug), doxorubicin hydrochloride (Drug), mechlorethamine hydrochloride (Drug), prednisone (Drug), procarbazine hydrochloride… to bleomycin (Drug), doxorubicin hydrochloride (Drug), mechlorethamine hydrochloride (Drug), prednisone (Drug), procarbazine hydrochloride…v11
  5. Publications: 2 to 3v10
  6. Re-verified, no change to tracked fieldsv9
  7. Interventions: bleomycin (Drug), chemotherapy (Procedure), doxorubicin hydrochloride (Drug), mechlorethamine hydrochloride (Drug), prednisone (Drug)… to bleomycin (Drug), doxorubicin hydrochloride (Drug), mechlorethamine hydrochloride (Drug), prednisone (Drug), procarbazine hydrochloride…v8
  8. 2 versions Re-verified since Dec 15, 2007, no change to tracked fieldsv6-v7
  9. Publications: details revised at 1 of 2 entriesv5
  10. 2 versions Re-verified since Sep 18, 2007, no change to tracked fieldsv3-v4
  11. Enrollment target: 1158
    • Start date: Sep 1993
    • Study description expanded, about 8 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
RATIONALE: Radiation therapy uses high-energy x-rays to kill cancer cells. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving radiation therapy together with combination chemotherapy may kill more cancer cells. It is not yet known whether radiation therapy is more effective with or without combination chemotherapy in treating patients with Hodgkin's lymphoma. PURPOSE: This randomized phase III trial is studying radiation therapy to see how well it works with or without combination chemotherapy in treating patients with previously untreated stage I or stage II Hodgkin's lymphoma.
Trial Details
NCT Number NCT00379041
Lead Sponsor European Organisation for Research and Treatment of Cancer - EORTC
Conditions
(from sponsor)		 Lymphoma
Related terms Hodgkin Disease, Lymphoma
Enrollment 1,158 participants
Start Date
Primary Completion (estimated)
Updated on ClinicalTrials.gov